Search

Your search keyword '"Prediabetic state -- Drug therapy"' showing total 92 results
Start Over Descriptor "Prediabetic state -- Drug therapy"
92 results on '"Prediabetic state -- Drug therapy"'

1. The 10 little-known red flag signs on the skin that could be potentially deadly diabetes; Skin specialists say there are red flags to watch for that warn of undiagnosed diabetes or pre-diabetes or that current treatment needs altering

Subjects
Diabetes therapy, Skin, Prediabetic state -- Drug therapy, Blood sugar, Type 2 diabetes -- Drug therapy, General interest, News, opinion and commentary, American Academy of Dermatology
Abstract

Byline: By, Elaine Blackburne Millions of people in the UK suffer from a potentially deadly condition -but hundreds of thousands more do not realise they have it. Latest figures from [...]

Published
2025

2. Aphaia Reports Positive Results from Phase 2 Trial Evaluating Lead Drug Formulation for Prediabetes Treatment

Subjects
Glucose tolerance tests, Dextrose, Glucose, Clinical trials, Prediabetic state -- Drug therapy, Arts and entertainment industries
Abstract

Aphaia Pharma, a clinical-stage company harnessing precision-targeted drug formulations to restore endogenous endocrine balance for the treatment of obesity and associated metabolic diseases, reported that its Phase 2 trial evaluating [...]

Published
2024

4. Aphaia Highlights Positive Results from Phase 2 Trial Evaluating Lead Drug Formulation for Prediabetes Treatment

Subjects
Glucose tolerance tests, Dextrose, Glucose, Clinical trials, Prediabetic state -- Drug therapy, Business, Business, international, Telecommunications industry
Abstract

Aphaia Pharma, a clinical-stage company harnessing precision-targeted drug formulations to restore endogenous endocrine balance for the treatment of obesity and associated metabolic diseases, reported that its Phase 2 trial evaluating [...]

Published
2024

5. Aphaia Updates on Positive Results from Phase 2 Trial Evaluating Lead Drug Formulation for Prediabetes Treatment

Subjects
Glucose tolerance tests, Dextrose, Glucose, Clinical trials, Prediabetic state -- Drug therapy, Business, Business, international, Telecommunications industry
Abstract

Aphaia Pharma, a clinical-stage company harnessing precision-targeted drug formulations to restore endogenous endocrine balance for the treatment of obesity and associated metabolic diseases, reported that its Phase 2 trial evaluating [...]

Published
2024

6. Diabetes drug could be approved to treat obese patients

Subjects
Mounjaro (Medication), Diabetes therapy, Hypoglycemic agents, Drug approval, Prediabetic state -- Drug therapy, Type 2 diabetes -- Drug therapy, Weight loss -- Drug therapy, Hypertension -- Drug therapy
Abstract

ANOTHER diabetes drug has been authorised to help overweight and obese patients with weight loss by the Medicines and Healthcare products Regulatory Agency. Patients with weight-related health problems such as […]

Published
2023

7. Calibrate Sets New Benchmark in Obesity Treatment: Demonstrates a Remarkable 18% Sustained Weight Loss for Members at 24 Months, Outperforming GLP-1 Medication Trials

Subjects
Weight loss maintenance, Prediabetic state -- Drug therapy, Weight loss -- Drug therapy, News, opinion and commentary
Abstract

NEW YORK--(BUSINESS WIRE)--Jan 31, 2024-- Calibrate, the leading clinician-guided and value-based obesity treatment program, is releasing groundbreaking new results from the largest real-world member cohort yet, with program-wide weight loss [...]

Published
2024

8. Calibrate Sets New Benchmark in Obesity Treatment: Demonstrates a Remarkable 18% Sustained Weight Loss for Members at 24 Months, Outperforming GLP-1 Medication Trials

Subjects
Weight loss maintenance, Prediabetic state -- Drug therapy, Weight loss -- Drug therapy, Business, Business, international
Abstract

Company Achieves Best-in-Class Outcomes in Weight Loss and Metabolic Health NEW YORK -- Calibrate, the leading clinician-guided and value-based obesity treatment program, is releasing groundbreaking new results from the largest [...]

Published
2024

10. United Kingdom : MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss

Subjects
Obesity -- Drug therapy, Diabetes therapy, Hypoglycemic agents, Prediabetic state -- Drug therapy, Weight loss -- Drug therapy, Hypertension -- Drug therapy, Business, international, Mounjaro (Medication)
Abstract

The Medicines and Healthcare products Regulatory Agency (MHRA) has (8 November 2023) authorised via a national application route, a new indication for the diabetes medicine, Mounjaro (tirzepatide), for weight loss [...]

Published
2023

11. Diabetes drug could be approved for weight loss; Health Secretary Steve Barclay said Mounjaro has the potential to help thousands of people living with obesity

Subjects
Obesity -- Drug therapy, Independent regulatory commissions, Diabetes therapy, Hypoglycemic agents, Drug approval, Prediabetic state -- Drug therapy, Type 2 diabetes -- Drug therapy, Weight loss -- Drug therapy, Hypertension -- Drug therapy, General interest, News, opinion and commentary, Mounjaro (Medication)
Abstract

Byline: Telegraph reporters Another diabetes drug has been authorised to help overweight and obese patients with weight loss by the Medicines and Healthcare products Regulatory Agency (MHRA). Patients with weight-related [...]

Published
2023

12. Six Percent With Prediabetes Develop Diabetes Within 1 Year

Subjects
Medical colleges -- Statistics -- Reports, Prediabetic state -- Drug therapy, Health
Abstract

HealthDay News — Six percent of individuals with prediabetes develop diabetes within 1 year, according to a study published online March 2 in the Journal of General Internal Medicine. Eva [...]

Published
2022

13. Research from Institute for Cancer Research and Treatment (IRCCS) Reveals New Findings on Type 2 Diabetes (DNA methylation profiling of CD04+/CD08+ T cells reveals pathogenic mechanisms in increasing hyperglycemia: PIRAMIDE pilot study)

Subjects
Drug therapy, Reports, Cancer treatment -- Reports, Cancer genetics -- Drug therapy, Cancer -- Drug therapy, Cancer research -- Reports, Methylation -- Reports, Hyperglycemia -- Drug therapy, Physical fitness -- Reports, Genetic research -- Reports, Type 2 diabetes -- Drug therapy, Diabetes therapy -- Reports, DNA -- Reports, Prediabetic state -- Drug therapy, T cells -- Reports, Diabetics -- Drug therapy
Abstract

2020 DEC 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Nutritional and Metabolic Diseases and Conditions - [...]

Published
2020

14. Gut bacteria linked to weight gain following chemotherapy treatment for breast cancer

Subjects
Bacteria -- Reports, Hypertension -- Drug therapy, Microbiota (Symbiotic organisms) -- Reports, Women's health -- Reports, Chemotherapy -- Reports, Prediabetic state -- Drug therapy, Breast cancer -- Drug therapy, Health, Women's issues/gender studies
Abstract

2020 NOV 5 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Approximately 30% of breast cancer patients who receive chemotherapy treatment gain weight, though it [...]

Published
2020

15. Peru : Health establishments in South Lima rule out diabetes and provide free treatment

Subjects
Blood -- Medical examination, Glucose tolerance tests, Diabetes therapy, Glycosylated hemoglobin, Prediabetic state -- Drug therapy, Type 2 diabetes -- Drug therapy, Business, international
Abstract

'At Diris Lima Sur we have 119 health establishments distributed from Barranco to Pucusana, where diabetes is ruled out free of charge, through glucose dosage, thus diagnosing the type of [...]

Published
2022

16. U-Haul Team Members Enrolled with Virta Health Eliminate Over One-Third of Diabetes Medications in Just 90 Days

Subjects
U-Haul International Inc., Hypoglycemic agents, Prediabetic state -- Drug therapy, Blood sugar, Lease and rental services industry, Type 2 diabetes -- Drug therapy, Business, Business, international
Abstract

Through Virta's treatment, one U-Haul Team Member lowered his blood sugar to prediabetes levels, reduced his daily insulin dosage by over 85%, and lost 30 pounds SAN FRANCISCO -- Type [...]

Published
2022

17. National Center for Global Health and Medicine Reports Findings in Epidemiology (Diabetes, Prediabetes, and the Risk of a Composite Outcome of Long-term Sickness Absence and Pre-retirement Death Due To Physical Disorders)

Subjects
World health -- Reports, Worker absenteeism -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Prediabetic state -- Drug therapy, Epidemiology -- Reports, Cardiovascular diseases -- Drug therapy, Health
Abstract

2023 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Investigators publish new report on Health and Medicine - Epidemiology. According to news reporting out [...]

Published
2023

18. Clinical considerations for insulin pharmacotherapy in ambulatory care, part one: introduction and review of current products and guidelines

Author

Galdo, John A., Thurston, Maria Miller, and Bourg, Catherine A.

Subjects
Eli Lilly and Co., United States. Centers for Disease Control and Prevention, American Diabetes Association, European Association for the Study of Diabetes, Drug therapy, Diabetes therapy, Pharmaceutical industry, Prediabetic state -- Drug therapy, Insulin
Abstract

The World Health Organization estimates that 347 million people worldwide have diabetes, making it a chronic disease of epidemic proportions. (1) In 2010, the Centers for Disease Control and Prevention [...]

Published
2014

19. Ilya Pharma announces FDA clearance of IND for first-in-class ILP100-Topical immunotherapy treatment of surgical wounds in patients with prediabetes, diabetes and obesity

Subjects
Obesity -- Drug therapy -- Surgery, Diabetes therapy -- Product development, Immunotherapy, Surgery, Plastic, Prediabetic state -- Drug therapy, Wounds and injuries -- Drug therapy, Business, News, opinion and commentary
Abstract

UPPSALA, Sweden, May 4, 2022 /PRNewswire/ -- Ilya Pharma AB (the Company), a clinical stage immunotherapy company today announced that FDA have cleared an IND for its lead candidate ILP100-Topical [...]

Published
2022

20. Alpha Medical Offers New Outpatient Diabetes Treatment and Care, Making Women's Specific Needs Attainable in a Truly Flexible Way

Subjects
Diabetes therapy, Health care industry, Hypoglycemic agents, Prediabetic state -- Drug therapy, Pregnant women -- Drug therapy, Type 2 diabetes -- Drug therapy, Weight loss industry, Health care industry, Business, News, opinion and commentary
Abstract

Leading telemedicine company dedicated to women's healthcare expands its services to treat Prediabetes, Type 2 Diabetes, and Gestational Diabetes through affordable and flexible treatment plans PALO ALTO, Calif., April 26, [...]

Published
2022

21. Fractyl Health Announces FDA IDE Approval to Begin Revitalize-2 Pivotal Study Designed for Patients with Type 2 Diabetes (T2D) Who Are Not Yet on Insulin

Subjects
United States. Food and Drug Administration, Medical research, Medicine, Experimental, Diabetes therapy, Insulin, Prediabetic state -- Drug therapy, Type 2 diabetes -- Drug therapy, Business, Business, international
Abstract

- Revitalize-2 is the second pivotal study for the Revita DMR([R]) system (Revita([R])) in Fractyl Health's Revitalize T2D clinical development program - - Revitalize T2D is designed to evaluate the [...]

Published
2022

22. New Findings from Institute for Regenerative Medicine Update Understanding of Type 2 Diabetes (An Increase In Inflammation and Islet Dysfunction Is a Feature of Prediabetes)

Subjects
Medical research, Medicine, Experimental, Inflammation -- Drug therapy, Prediabetic state -- Drug therapy, Type 2 diabetes -- Drug therapy, Health
Abstract

2022 SEP 30 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Nutritional and Metabolic Diseases and Conditions - Type 2 [...]

Published
2022

23. OF MEDICINE'S MISSED OPPORTUNITIES, DIABETES PREVENTION NEARS THE TOP

Subjects
Medicine, Preventive -- Reports, Medical societies -- Reports, Prediabetic state -- Drug therapy, Preventive health services -- Reports, Type 2 diabetes -- Drug therapy, Evidence-based medicine -- Reports, News, opinion and commentary
Abstract

CHICAGO, IL -- The following information was released by the American Medical Association (AMA): Timothy M. Smith Type 2 diabetes has reached epidemic status in the U.S., but you might [...]

Published
2022

24. Study Data from Harvard University T.H. Chan School of Public Health Update Understanding of Type 2 Diabetes (Transcultural Lifestyle Medicine in Type 2 Diabetes Care: Narrative Review of the Literature)

Subjects
Diabetes therapy, Chronic diseases -- Drug therapy, Insulin resistance -- Drug therapy, Prediabetic state -- Drug therapy, Type 2 diabetes -- Drug therapy, Health
Abstract

2022 JUN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on type 2 diabetes. According to news originating from [...]

Published
2022

25. Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome

Author

Russell, James C., Kelly, Sandra E., Diane, Abdoulaye, Wang, Ye, Mangat, Rabban, Novak, Susan, Vine, Donna F., and Proctor, Spencer D.

Subjects
Prediabetic state -- Development and progression, Prediabetic state -- Drug therapy, Kidney diseases -- Development and progression, Kidney diseases -- Drug therapy, Lipid metabolism -- Observations, Biological sciences
Abstract

Rimonabant (SR 141716) is a specific antagonist of the cannabinoid- 1 receptor. Activation of the receptor initiates multiple effects on central nervous system function, metabolism, and body weight. The hypothesis that rimonabant has protective effects against vascular disease associated with the metabolic syndrome was tested using JCR:LA-cp rats. JCR:LA-cp rats are obese if they are cp/cp, insulin resistant, and exhibit associated micro- and macrovascular disease with end-stage myocardial and renal disease. Treatment of obese rats with rimonabant (10 mg x [kg.sup.-1] x [day.sup.-1], 12-24 wk of age) caused transient reduction in food intake for 2 wk, without reduction in body weight. However, by 4 wk, there was a modest, sustained reduction in weight gain. Glycemic control improved marginally compared with controls, but at the expense of increased insulin concentration. In contrast, rimonabant normalized fasting plasma triglyceride and reduced plasma plasminogen activator inhibitor-1 and acute phase protein haptoglobin in cp/cp rats. Furthermore, these changes were accompanied by reduced postprandial intestinal lymphatic secretion of apolipoprotein B48, cholesterol, and haptoglobin. While macrovascular dysfunction and ischemic myocardial lesion frequency were unaffected by rimonabant treatment, both microalbuminuria and glomerular sclerosis were substantially reduced. In summary, rimonabant has a modest effect on body weight in freely eating obese rats and markedly reduces plasma triglyceride levels and microvascular disease, in part due to changes in intestinal metabolism, including lymphatic secretion of apolipoprotein B48 and haptoglobin. We conclude that rimonabant improves renal disease and intestinal lipid oversecretion associated with an animal model of the metabolic syndrome that appears to be independent of hyperinsulinemia or macrovascular dysfunction. metabolic syndrome; chylomicron overproduction; inflammation; microalbuminuria; glomerular sclerosis; plasminogen activator inhibitor-1; apolipoprotein B48 doi: 10.1152/ajpgi.00173.2010.

Published
2010

26. The Allurion Program, an Emerging Novel Treatment for Type 2 Diabetes and Prediabetes

Subjects
Diabetes therapy, Obesity -- Surgery, Prediabetic state -- Drug therapy, Type 2 diabetes -- Drug therapy, Weight loss -- Drug therapy, Business, international
Abstract

The 'silent pandemic': One in five in the UAE has diabetes, which is three times deadlier than COVID-19. Dubai, UAE: On 9th November 2021, Allurion, the world's first and only [...]

Published
2021

27. Findings from Institute for Cancer Research and Treatment (IRCCS) Advance Knowledge in Cardiovascular Diabetology (Lower miR-21/ROS/HNE levels associate with lower glycemia after habit-intervention: DIAPASON study 1-year later)

Subjects
Oncology, Experimental -- Reports, Cancer -- Care and treatment -- Drug therapy -- Research, Prediabetic state -- Drug therapy, Type 2 diabetes -- Drug therapy, Health
Abstract

2022 MAR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Investigators publish new report on cardiovascular diabetology. According to news originating from the Institute for [...]

Published
2022

30. Effect of renin-angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose tolerance

Author

Pscherer, Stefan, Heemann, Uwe, and Frank, Helga

Subjects
Drug therapy, Physiological aspects, Patient outcomes, Dosage and administration, Health aspects, Angiotensin II receptor blockers -- Dosage and administration -- Patient outcomes, C-reactive protein -- Physiological aspects -- Health aspects, Renin-angiotensin system -- Health aspects, Insulin resistance -- Drug therapy, Prediabetic state -- Drug therapy
Abstract

OBJECTIVE--The study investigated the effect of angiotensin receptor blockers (ARB) on glucose homeostasis and inflammatory parameters in patients with impaired glucose tolerance (IGT). RESEARCH DESIGN AND METHODS--We prospectively studied the [...]

Published
2010
Full Text
View/download PDF

31. Approaches to treatment of pre-diabetes and obesity and promising new approaches to type 2 diabetes

Author

Bloomgarden, Zachary T.

Subjects
Mount Sinai School of Medicine, Obesity -- Drug therapy, Diabetes therapy, Continuing medical education, Prediabetic state -- Drug therapy, Type 2 diabetes -- Drug therapy, Health, Drug therapy
Abstract

Perspectives on the News commentaries are part of a free monthly CME activity. The Mount Sinai School of Medicine, New York, New York, designates this activity for 2.0 AMA PRA [...]

Published
2008

32. Virta Health Adds Prediabetes Reversal, Obesity Treatment, and Provider-Led Diabetes Management to Clinical Services

Subjects
Obesity -- Drug therapy, Evidence-based medicine, Type 2 diabetes -- Drug therapy, Diabetes therapy, Prediabetic state -- Drug therapy, Company business management, Business, Business, international
Abstract

Expansion gives payers a single, evidence-based virtual provider that provides disease reversal for multiple metabolic conditions SAN FRANCISCO -- Virta Health, the leader in type 2 diabetes reversal, today introduced [...]

Published
2020

33. Report Summarizes Obesity and Diabetes Study Findings from Curtin University (TNFSF14-Derived Molecules as a Novel Treatment for Obesity and Type 2 Diabetes)

Subjects
Diabetes therapy, Diabetes -- Research, Insulin resistance -- Drug therapy, Prediabetic state -- Drug therapy, Type 2 diabetes -- Drug therapy, Health
Abstract

2021 OCT 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- A new study on obesity and diabetes is now available. According to news [...]

Published
2021

34. Investigators at Michigan State University Report Findings in Bioethics (Are Corporations Re-defining Illness and Health? the Diabetes Epidemic, Goal Numbers, and Blockbuster Drugs)

Subjects
Diabetes therapy -- Statistics -- Ethical aspects, Bioethics -- Reports -- Statistics, Prediabetic state -- Drug therapy, Type 2 diabetes -- Drug therapy, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2021 OCT 6 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Investigators discuss new findings in Biotechnology - Bioethics. According to news reporting originating in East [...]

Published
2021

35. The relationship between severe mental illness and diabetes

Subjects
Type 2 diabetes -- Research, Type 2 diabetes -- Drug therapy, Type 2 diabetes -- Risk factors, Type 2 diabetes -- Surveys, Type 2 diabetes -- Physiological aspects, Type 2 diabetes -- Analysis, Type 2 diabetes -- Reports, Bipolar disorder -- Research, Bipolar disorder -- Drug therapy, Bipolar disorder -- Risk factors, Bipolar disorder -- Surveys, Bipolar disorder -- Physiological aspects, Bipolar disorder -- Analysis, Bipolar disorder -- Reports, Blood sugar monitoring -- Surveys, Blood sugar monitoring -- Physiological aspects, Blood sugar monitoring -- Analysis, Blood sugar monitoring -- Reports, Antipsychotic drugs -- Research, Antipsychotic drugs -- Surveys, Antipsychotic drugs -- Physiological aspects, Antipsychotic drugs -- Analysis, Antipsychotic drugs -- Reports, Glucose tolerance tests -- Surveys, Glucose tolerance tests -- Physiological aspects, Glucose tolerance tests -- Analysis, Glucose tolerance tests -- Reports, Prediabetic state -- Research, Prediabetic state -- Drug therapy, Prediabetic state -- Risk factors, Prediabetic state -- Surveys, Prediabetic state -- Physiological aspects, Prediabetic state -- Analysis, Prediabetic state -- Reports, Blood sugar -- Surveys, Blood sugar -- Physiological aspects, Blood sugar -- Analysis, Blood sugar -- Reports, Medical research -- Surveys, Medical research -- Physiological aspects, Medical research -- Analysis, Medical research -- Reports, Medicine, Experimental -- Surveys, Medicine, Experimental -- Physiological aspects, Medicine, Experimental -- Analysis, Medicine, Experimental -- Reports, Carbohydrate metabolism -- Surveys, Carbohydrate metabolism -- Physiological aspects, Carbohydrate metabolism -- Analysis, Carbohydrate metabolism -- Reports, Obesity -- Research, Obesity -- Drug therapy, Obesity -- Risk factors, Obesity -- Surveys, Obesity -- Physiological aspects, Obesity -- Analysis, Obesity -- Reports, Hyperglycemia -- Research, Hyperglycemia -- Drug therapy, Hyperglycemia -- Risk factors, Hyperglycemia -- Surveys, Hyperglycemia -- Physiological aspects, Hyperglycemia -- Analysis, Hyperglycemia -- Reports, Somatotropin -- Research, Somatotropin -- Surveys, Somatotropin -- Physiological aspects, Somatotropin -- Analysis, Somatotropin -- Reports, Glucose metabolism -- Surveys, Glucose metabolism -- Physiological aspects, Glucose metabolism -- Analysis, Glucose metabolism -- Reports, Dementia -- Research, Dementia -- Drug therapy, Dementia -- Risk factors, Dementia -- Surveys, Dementia -- Physiological aspects, Dementia -- Analysis, Dementia -- Reports, Schizophrenia -- Research, Schizophrenia -- Drug therapy, Schizophrenia -- Risk factors, Schizophrenia -- Surveys, Schizophrenia -- Physiological aspects, Schizophrenia -- Analysis, Schizophrenia -- Reports, Chronic diseases -- Research, Chronic diseases -- Drug therapy, Chronic diseases -- Risk factors, Chronic diseases -- Surveys, Chronic diseases -- Physiological aspects, Chronic diseases -- Analysis, Chronic diseases -- Reports, Insulin resistance -- Research, Insulin resistance -- Surveys, Insulin resistance -- Physiological aspects, Insulin resistance -- Analysis, Insulin resistance -- Reports, Leptin -- Surveys, Leptin -- Physiological aspects, Leptin -- Analysis, Leptin -- Reports, Diabetes therapy -- Surveys, Diabetes therapy -- Physiological aspects, Diabetes therapy -- Analysis, Diabetes therapy -- Reports, Eating disorders -- Research, Eating disorders -- Drug therapy, Eating disorders -- Risk factors, Eating disorders -- Surveys, Eating disorders -- Physiological aspects, Eating disorders -- Analysis, Eating disorders -- Reports, Peptide hormones -- Surveys, Peptide hormones -- Physiological aspects, Peptide hormones -- Analysis, Peptide hormones -- Reports, Corticosteroids -- Research, Corticosteroids -- Surveys, Corticosteroids -- Physiological aspects, Corticosteroids -- Analysis, Corticosteroids -- Reports, Health
Published
2003

37. PROSPECTS OF NEW TREATMENTS FOR DIABETES THROUGH METABOLIC PRODUCTS OF THE INTESTINAL FLORA

Subjects
Metabolites, Microbiota (Symbiotic organisms), Type 2 diabetes -- Drug therapy, Diabetes therapy, Prediabetic state -- Drug therapy, Biochemistry, Canadians, Insulin, News, opinion and commentary, University of Paris-Sorbonne, Kyoto University, McGill University
Abstract

MONTREAL, Quebec, Canada -- The following information was released by McGill University: In a study published in the journal Cell Reports, researchers at McGill University, Kyoto University and INSERM/University of [...]

Published
2020

38. Diabetes and hypertension drug combo kills cancer cells

Subjects
Cancer -- Drug therapy, Hypertension -- Drug therapy, Combination drug therapy, Medical research, Blood glucose, Type 2 diabetes -- Drug therapy, Diabetes therapy, Insulin resistance -- Drug therapy, Prediabetic state -- Drug therapy, Obesity, Weight loss, Polycystic ovary syndrome, Scientists, Physicians, Metformin, Insulin, Liver, Cancer cells, Glucose, News, opinion and commentary
Abstract

Metformin is a common drug in the fight against type 2 diabetes, medicalnewstoday.com wrote.It lowers blood sugar by slowing the release of glucose from the liver and the absorption of [...]

Published
2018

39. Diabetes Drug Eases Pain

Subjects
Hypoglycemic agents, Diabetes therapy, Insulin resistance -- Drug therapy, Fibromyalgia -- Drug therapy, Prediabetic state -- Drug therapy, Medical research, Insulin, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

A correlation between insulin resistance and fibromyalgia led researchers to put some patients with fibromyalgia and prediabetes or diabetes on metformin, and they found their pain scores declined [...]

Published
2019

40. Lifestyle modifications versus pharmacologic treatment for patients with diabetes

Author

Olivieri, Chrystyne

Subjects
Drug therapy, Hypoglycemic agents, Type 2 diabetes -- Drug therapy, Prediabetic state -- Drug therapy, Diabetics -- Drug therapy
Abstract

I could hardly contain my anger and frustration while reading the comment by Joel Zonszein, MD, CDE, in 'A differing opinion on the ACP's New Diabetes Treatment Guidelines' [Advisor Forum, [...]

Published
2017

41. Joslin researchers identify new target for treatment of type 2 diabetes and prediabetes

Subjects
Drug therapy, Type 2 diabetes -- Drug therapy, Diabetes therapy, Enzymes, Prediabetic state -- Drug therapy, Mitochondrial DNA
Abstract

Researchers at the Joslin Diabetes Center have shown that an enzyme found in the mitochondria of cells is decreased in the skeletal muscle of those with diabetes, a finding that [...]

Published
2011

42. Research Data from Nagoya University School of Medicine Update Understanding of Diabetes

Subjects
Drug therapy, Apoptosis -- Drug therapy, Universities and colleges -- Japan, Diabetes mellitus -- Drug therapy, Cysteine proteinases, Proteases, Prediabetic state -- Drug therapy, Diabetes -- Drug therapy
Abstract

New investigation results, 'Palmitate induces apoptosis in Schwann cells via both ceramide-dependent and independent pathways,' are detailed in a study published in Neuroscience. According to a study from Nagoya, Japan, [...]

Published
2011

43. Diabetes drug can cut obesity in non-diabetics

Subjects
Obesity -- Drug therapy, Diabetes therapy, Hypoglycemic agents, Prediabetic state -- Drug therapy, News, opinion and commentary
Abstract

The diabetes drug liraglutide could be used to treat obesity in non-diabetics and could also cut the risk of prediabetes, Danish research suggests. The latest findings come as Diabetes UK [...]

Published
2009

44. Investigators from Institute for Cancer Research and Treatment (IRCCS) Have Reported New Data on Prediabetic State (Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state)

Subjects
Drug therapy, Cancer -- Drug therapy, Cancer research, Prediabetic state -- Drug therapy
Abstract

2018 APR 30 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Researchers detail new data in Nutritional and Metabolic Diseases and Conditions - Prediabetic State. According [...]

Published
2018

46. UCSF Diabetes Center Forms Precision Medicine Initiative with All-Mobile Type 2 Diabetes Prevention Program, Yes Health

Subjects
Precision medicine, Type 2 diabetes -- Drug therapy, Diabetes therapy, Prediabetic state -- Drug therapy, Blood glucose, Business, News, opinion and commentary
Abstract

UCSF researchers to gain access to real-time behavioral data to aid development of personalized type 2 diabetes prevention and treatment strategies SAN FRANCISCO, March 15, 2016 /PRNewswire/ -- This week, [...]

Published
2016

47. Pre-diabetes discovery marks step towards precision medicine

Subjects
Drug therapy, Precision medicine, Hypertension -- Drug therapy, Diabetes therapy, Insulin resistance -- Drug therapy, Hyperglycemia -- Drug therapy, Blood glucose, Prediabetic state -- Drug therapy
Abstract

2017 DEC 8 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers from the University of Sydney's Charles Perkins Centre have identified three specific [...]

Published
2017

48. Troglitazone: New Oral Hypoglycemic Agent

Subjects
Warner-Lambert Co. Parke-Davis Div., Prediabetic state -- Drug therapy, Blood platelets -- Aggregation, Diabetes therapy, Pharmaceutical industry, Thiazolidinediones, Troglitazone, Insulin resistance, Health
Abstract

Pharmacology Update Troglitazone: New Oral Hypoglycemic Agent By William T. Elliott, MD, FACP, and James Chan, PharmD, PhD The fda has approved troglitazone, a new oral hypoglycemic agent, for the [...]

Published
1997

49. Eat, Chew, Live - A New Book by Dr. John Poothullil - Offers a Radical New Approach to Prevent or Reverse Type 2 Diabetes without Medication, Saving Billions of Dollars

Subjects
Books, Type 2 diabetes -- Drug therapy, Insulin resistance -- Drug therapy, Blood glucose, Prediabetic state -- Drug therapy, Business, general
Abstract

Los Angeles, CA (PRWEB) June 17, 2015 Diabetes is at nearly pandemic levels, with 1 in 4 adults over 65 in the US being fully diabetic and 1 in 3 [...]

Published
2015

50. Dh9m centre to provide treatment for diabetes

Subjects
Diabetes therapy, Clinics, Prediabetic state -- Drug therapy, Business, Business, international
Abstract

Abu Dhabi: A Dh9 million outpatient facility by UE Medical was inaugurated in the capital today (Sunday), with the aim of offering multidisciplinary care to diabetics and pre-diabetic patients. The [...]

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results